Pharma and SM: one minute it’s on,…
… the next it’s off.
“Old familiar worries” are “about adverse event and off-label discussions compounded by the delay of FDA guidelines”.
“companies that abandon Facebook will miss out on a “powerful community that is already woven into billions of lives whose voices want and need to be heard“.
- Sanofi’s VOICES Facebook page
- Bayer’s tweets mistakes
- Roche SM guideline
- J&J Children with diabetes community
- AstraZeneca Twitter discussion